We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KMI:NYSEKinder Morgan, Inc. Analysis

Data as of 2026-05-25 - not real-time

$33.79

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kinder Morgan delivered a strong Q1, driven by a surge in natural‑gas demand that helped the company beat earnings estimates and lift the share price about 3% after a brief pullback. Insider buying over the past 12 months adds confidence in the management’s outlook. The stock is trading at $33.79, comfortably above the 20‑day (32.64) and 50‑day (32.75) SMAs and well above the 200‑day SMA (29.33), indicating a bullish bias. Momentum indicators are supportive: the RSI sits at 60.7, the MACD histogram is positive and the MACD signal is bullish. Volume, however, is on a decreasing trend, which tempers short‑term enthusiasm. The price sits near the identified resistance of $34.81, with a solid support base at $30.73, suggesting limited upside in the near term. Valuation metrics show a P/E of 22.68, modestly higher than the industry average of 21.63, while the DCF model implies a slight undervaluation with a 4.5% upside to the consensus target of $35.33. The dividend yield of 3.48% is attractive, and a payout ratio of 78.5% appears sustainable given robust operating cash flow of $6.25 B and free cash flow of $1.65 B. The company’s beta is low, but 30‑day volatility is elevated at 22.4%, reflecting market sensitivity to energy price swings. Overall, the combination of strong earnings, insider confidence, solid cash generation, and a respectable dividend makes KMI a compelling blend of growth and value, though investors should watch for regulatory headwinds in the midstream sector.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive Q1 earnings and rising natural‑gas demand
  • Technical indicators showing bullish momentum
  • Insider buying reinforcing confidence

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable cash flow supporting dividend sustainability
  • Slight valuation upside to target price
  • Continued demand growth for midstream infrastructure

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Exposure to regulatory and environmental policy changes
  • High payout ratio may limit future growth
  • Strong balance sheet but elevated leverage

Key Metrics & Analysis

Financial Health

Revenue Growth13.80%
Profit Margin18.92%
P/E Ratio22.7
ROE10.60%
ROA4.32%
Debt/Equity98.84
P/B Ratio2.4
Op. Cash Flow$6.2B
Free Cash Flow$1.6B
Industry P/E21.6

Technical Analysis

TrendNeutral
RSI60.7
Support$30.73
Resistance$34.81
MA 20$32.64
MA 50$32.75
MA 200$29.33
MACDBullish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

Fair Value$2.68
Target Price$35.33
Upside/Downside4.57%
GradeFair
TypeBlend
Dividend Yield3.48%

Risk Assessment

Beta0.03
Volatility22.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.